Black Friday Savings ! Exclusive Deals on Latest Pharma and Medical Technology Reports.

Explore Now

Opioid Related Disorders Epidemiology Forecast

DelveInsight's "Opioid-related Disorders - Epidemiology Forecast to 2030" report delivers an in-depth understanding of the disease, historical and forecasted Opioid-related Disorders epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2018-2030

Opioid-related Disorders Understanding

The DelveInsight Opioid-related Disorders epidemiology report gives a thorough understanding of the Opioid-related Disorders by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Opioid-related Disorders in the US, Europe, and Japan. The report covers the detailed information of the Opioid-related Disorders epidemiology scenario in seven major countries (US, EU5, and Japan).

Opioid-related Disorders Epidemiology Perspective by DelveInsight

The Opioid-related Disorders epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Opioid-related Disorders epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Opioid-related Disorders epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2018 to 2030. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.

Opioid-related Disorders Detailed Epidemiology Segmentation

The Opioid-related Disorders epidemiology covered in the report provides historical as well as forecasted Opioid-related Disorders epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2018 to 2030.


The DelveInsight Opioid-related Disorders report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.

Scope of the Report

  • The Opioid-related Disorders report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Opioid-related Disorders Epidemiology Report and Model provide an overview of the global trends of Opioid-related Disorders in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight into the historical and forecasted patient pool of Opioid-related Disorders in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps recognize the growth opportunities in the 7MM for the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Opioid-related Disorders
  • The report provides the segmentation of the Opioid-related Disorders epidemiology

Report Highlights

  • 11-year Forecast of Opioid-related Disorders epidemiology
  • 7MM Coverage
  • Prevalent and Diagnosed Cases of Opioid-related Disorders
  • Cases of Opioid-related Disorders by Mutation Types
  • Opioid-related Disorders Cases associated with Clinical Manifestations

KOL views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.

Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Opioid-related Disorders?
  • What are the key findings pertaining to the Opioid-related Disorders epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2018-2030)?
  • What would be the total number of patients of Opioid-related Disorders across the 7MM during the forecast period (2018-2030)?
  • Among the EU5 countries, which country will have the highest number of patients during the forecast period (2018-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2018-2030)?
  • What is the disease risk, burden and unmet needs of Opioid-related Disorders?
  • What are the currently available treatments of Opioid-related Disorders?

Reasons to buy

The Opioid-related Disorders Epidemiology report will allow the user to -

  • Develop business strategies by understanding the trends shaping and driving the global Opioid-related Disorders market
  • Quantify patient populations in the global Opioid-related Disorders market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Opioid-related Disorders therapeutics in each of the markets covered
  • Understand the magnitude of Opioid-related Disorders population by its epidemiology
  • The Opioid-related Disorders Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

Key Assessments

  • Patient Segmentation
  • Disease Risk & Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Opioid-related Disorders

3. Opioid-related Disorders: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Opioid-related Disorders Epidemiology Scenario in the 7MM (2018- 2030)

5.4. United States Epidemiology

5.4.1. Opioid-related Disorders Epidemiology Scenario in the United States (2018- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Opioid-related Disorders Epidemiology Scenario in Germany (2018- 2030)

5.5.2. France Epidemiology

5.5.2.1. Opioid-related Disorders Epidemiology Scenario in France (2018- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Opioid-related Disorders Epidemiology Scenario in Italy (2018- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Opioid-related Disorders Epidemiology Scenario in Spain (2018- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Opioid-related Disorders Epidemiology Scenario in the United Kingdom (2018-2030)

5.6. Japan Epidemiology

5.6.1. Opioid-related Disorders Epidemiology Scenario in Japan (2018- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Opioid-related Disorders Treatment and Management

6.2. Opioid-related Disorders Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

List of Tables

Table 1:  Opioid-related Disorders Epidemiology in 7MM (2018-2030)

Table 2: Opioid-related Disorders Diagnosed and Treatable Cases in 7MM (2018-2030)

Table 3: Opioid-related Disorders Epidemiology in the United States (2018-2030)

Table 4: Opioid-related Disorders Diagnosed and Treatable Cases in the United States (2018-2030)

Table 5: Opioid-related Disorders Epidemiology in Germany (2018-2030)

Table 6: Opioid-related Disorders Diagnosed and Treatable Cases in Germany (2018-2030)

Table 7: Opioid-related Disorders Epidemiology in France (2018-2030)

Table 8: Opioid-related Disorders Diagnosed and Treatable Cases in France (2018-2030)

Table 9: Opioid-related Disorders Epidemiology in Italy (2018-2030)

Table 10: Opioid-related Disorders Diagnosed and Treatable Cases in Italy (2018-2030)

Table 11: Opioid-related Disorders Epidemiology in Spain (2018-2030)

Table 12: Opioid-related Disorders Diagnosed and Treatable Cases in Spain (2018-2030)

Table 13: Opioid-related Disorders Epidemiology in the United Kingdom (2018-2030)

Table 14: Opioid-related Disorders Diagnosed and Treatable Cases in the United Kingdom (2018-2030)

Table 15: Opioid-related Disorders Epidemiology in Japan (2018-2030)

Table 16: Opioid-related Disorders Diagnosed and Treatable Cases in Japan (2018-2030)

List of Figures

Figure 1 Opioid-related Disorders Epidemiology in 7MM (2018-2030)

Figure 2 Opioid-related Disorders Diagnosed and Treatable Cases in 7MM (2018-2030)

Figure 3 Opioid-related Disorders Epidemiology in the United States (2018-2030)

Figure 4 Opioid-related Disorders Diagnosed and Treatable Cases in the United States (2018-2030)

Figure 5  Opioid-related Disorders Epidemiology in Germany (2018-2030)

Figure 6  Opioid-related Disorders Diagnosed and Treatable Cases in Germany (2018-2030)

Figure 7  Opioid-related Disorders Epidemiology in France (2018-2030)

Figure 8 Opioid-related Disorders Diagnosed and Treatable Cases in France (2018-2030)

Figure 9 Opioid-related Disorders Epidemiology in Italy (2018-2030)

Figure 10 Opioid-related Disorders Diagnosed and Treatable Cases in Italy (2018-2030)

Figure 11 Opioid-related Disorders Epidemiology in Spain (2018-2030)

Figure 12 Opioid-related Disorders Diagnosed and Treatable Cases in Spain (2018-2030)

Figure 13 Opioid-related Disorders Epidemiology in the United Kingdom (2018-2030)

Figure 14 Opioid-related Disorders Diagnosed and Treatable Cases in the United Kingdom (2018-2030)

Figure 15 Opioid-related Disorders Epidemiology in Japan (2018-2030)

Figure 16 Opioid-related Disorders Diagnosed and Treatable Cases in Japan (2018-2030)

*The table of contents is not exhaustive; will be provided in the final report


Forward to Friend

Need A Quote